Drawing for SPEXIS

USPTO serial 97041607

SPEXIS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
VO, KOMAL MAKHDOOM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPEXIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey C. Friends

Stacey C. Friends MORSE480 TOTTEN POND ROAD, 4TH FLOORWALTHAM, MA 02451United States

Goods and services

ClassDescriptionStatusFirst use
005Bactericides; Biocides; Fungicides for agricultural use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-bacterial and anti-fungal drugs for medical or veterinary purposesACTIVE—
042Drug discovery services; Pharmaceutical drug development servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 29, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 29, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 29, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 27, 2023EX2GSOU EXTENSION 2 GRANTED—
Sep 27, 2023EXT2SOU EXTENSION 2 FILED—
Sep 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 24, 2023EX1GSOU EXTENSION 1 GRANTED—
Mar 24, 2023EXT1SOU EXTENSION 1 FILED—
Mar 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 27, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 2, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 2, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2022DOCKASSIGNED TO EXAMINER—
Oct 25, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance